Total Payments
$9,466
2024 Payments
$1,918
Companies
72
Transactions
490
Medicare Patients
29,078
Medicare Billing
$5.8M
Payment Breakdown by Category
Food & Beverage$9,027 (95.4%)
Education$438.59 (4.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,027 | 479 | 95.4% |
| Education | $438.59 | 11 | 4.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,014 | 51 | $0 (2024) |
| Merck Sharp & Dohme LLC | $695.47 | 35 | $0 (2024) |
| Pharmacyclics LLC, An AbbVie Company | $589.09 | 29 | $0 (2023) |
| Janssen Biotech, Inc. | $578.44 | 28 | $0 (2024) |
| Amgen Inc. | $412.44 | 21 | $0 (2023) |
| Genentech USA, Inc. | $375.60 | 23 | $0 (2024) |
| PFIZER INC. | $349.07 | 32 | $0 (2024) |
| GENZYME CORPORATION | $294.63 | 14 | $0 (2024) |
| Daiichi Sankyo Inc. | $294.19 | 13 | $0 (2024) |
| Incyte Corporation | $279.03 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,918 | 87 | Novartis Pharmaceuticals Corporation ($199.33) |
| 2023 | $2,449 | 102 | Janssen Biotech, Inc. ($248.42) |
| 2022 | $1,605 | 79 | Pharmacyclics LLC, an AbbVie Company ($253.59) |
| 2021 | $902.25 | 55 | Pharmacyclics LLC, An AbbVie Company ($139.44) |
| 2020 | $423.01 | 21 | Amgen Inc. ($115.10) |
| 2019 | $264.50 | 18 | Merck Sharp & Dohme Corporation ($63.68) |
| 2018 | $936.56 | 60 | Novartis Pharmaceuticals Corporation ($183.16) |
| 2017 | $966.94 | 68 | Novartis Pharmaceuticals Corporation ($116.81) |
All Payment Transactions
490 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Oncology | ||||||
| 12/12/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $25.54 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Adaptive Biotechnologies Corporation | clonoSEQ (Device) | Food and Beverage | Cash or cash equivalent | $21.80 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/15/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 11/12/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $30.21 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Janssen Biotech, Inc. | TALVEY (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: ONCOLOGY | ||||||
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | OPDUALAG (Drug) | Food and Beverage | Cash or cash equivalent | $20.94 | General |
| Category: Oncology | ||||||
| 10/18/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $8.11 | General |
| Category: Hematology | ||||||
| 10/16/2024 | PFIZER INC. | BRAFTOVI (Drug), MEKTOVI | Education | In-kind items and services | $13.04 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 10/10/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $37.95 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/26/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $24.98 | General |
| Category: Hematology | ||||||
| 09/25/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $33.34 | General |
| Category: ONCOLOGY | ||||||
| 09/12/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: Oncology | ||||||
| 09/05/2024 | ABBVIE INC. | EPKINLY (Drug), IMBRUVICA | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: ONCOLOGY | ||||||
| 08/27/2024 | Kyowa Kirin, Inc. | Poteligeo (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Monoclonal Antibody | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Oncology | ||||||
| 08/20/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Oncology | ||||||
| 08/13/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $33.98 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 70 | 5,840 | 106,150 | $5.1M | $1.0M |
| 2022 | 87 | 8,018 | 176,619 | $9.4M | $1.9M |
| 2021 | 97 | 8,844 | 225,847 | $9.9M | $2.0M |
| 2020 | 78 | 6,376 | 151,166 | $4.4M | $879,649 |
Total Patients
29,078
Total Services
659,782
Medicare Billing
$5.8M
Procedure Codes
332
All Medicare Procedures & Services
332 procedure records from CMS Medicare Utilization — Page 1 of 14
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | Office | 2023 | 11 | 9,200 | $1.6M | $379,178 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 532 | 1,664 | $695,369 | $147,989 | 21.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 34 | 5,100 | $379,695 | $89,633 | 23.6% |
| J1437 | Injection, ferric derisomaltose, 10 mg | Office | 2023 | 31 | 3,600 | $286,200 | $54,607 | 19.1% |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2023 | 31 | 8,670 | $362,666 | $47,687 | 13.1% |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | Office | 2023 | 26 | 118 | $249,546 | $38,107 | 15.3% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 76 | 372 | $219,060 | $35,374 | 16.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 145 | 262 | $129,572 | $34,303 | 26.5% |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 2023 | 58 | 60,690 | $212,415 | $22,473 | 10.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 498 | 1,584 | $20,222 | $13,292 | 65.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 508 | 1,685 | $64,653 | $12,795 | 19.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 68 | 557 | $131,987 | $11,858 | 9.0% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2023 | 24 | 575 | $79,845 | $8,920 | 11.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 52 | 52 | $36,886 | $8,324 | 22.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 331 | 637 | $42,227 | $6,573 | 15.6% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 27 | 135 | $34,279 | $6,455 | 18.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 136 | 615 | $47,853 | $6,195 | 12.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 88 | $24,863 | $5,563 | 22.4% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 33 | 36 | $40,440 | $5,530 | 13.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 66 | 109 | $31,527 | $4,996 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 40 | 40 | $22,498 | $4,842 | 21.5% |
| 83615 | Lactate dehydrogenase (enzyme) level | Office | 2023 | 338 | 700 | $20,867 | $4,139 | 19.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 188 | 300 | $14,313 | $3,995 | 27.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 172 | 263 | $19,580 | $3,872 | 19.8% |
| 96360 | Infusion into a vein for hydration, 31-60 minutes | Office | 2023 | 47 | 159 | $24,185 | $3,809 | 15.8% |
About Dr. Frederick Flynt, M.D
Dr. Frederick Flynt, M.D is a Hematology & Oncology healthcare provider based in Athens, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1235356247.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Frederick Flynt, M.D has received a total of $9,466 in payments from pharmaceutical and medical device companies, with $1,918 received in 2024. These payments were reported across 490 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($9,027).
As a Medicare-enrolled provider, Flynt has provided services to 29,078 Medicare beneficiaries, totaling 659,782 services with total Medicare billing of $5.8M. Data is available for 4 years (2020–2023), covering 332 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Athens, GA
- Active Since 04/19/2007
- Last Updated 07/17/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235356247
Products in Payments
- IMBRUVICA (Drug) $651.82
- KEYTRUDA (Biological) $643.13
- DARZALEX (Biological) $317.46
- MEKINIST (Drug) $312.88
- KISQALI (Drug) $241.85
- Enhertu (Drug) $229.39
- ZEJULA (Drug) $193.64
- LYNPARZA (Drug) $180.59
- Orserdu (Drug) $175.78
- LIBTAYO (Biological) $172.89
- IBRANCE (Drug) $153.28
- VERZENIO (Drug) $140.37
- SIR-Spheres Microspheres (Device) $138.35
- VENCLEXTA (Drug) $128.87
- XTANDI (Drug) $122.28
- ALOXI (Drug) $120.87
- ADCETRIS (Biological) $118.72
- XPOVIO (Drug) $117.57
- NINLARO (Drug) $111.32
- Nplate (Biological) $110.54
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Athens
Dr. Priya Rudolph, Md, Phd, MD, PHD
Hematology & Oncology — Payments: $666,297
Hematology & Oncology $666,297
Amanda Hathaway, M.d, M.D
Hematology & Oncology — Payments: $147,716
Hematology & Oncology $147,716
Dr. Charles Bodine, M.d, M.D
Hematology & Oncology — Payments: $9,979
Hematology & Oncology $9,979
Shawn Tai, M.d, M.D
Hematology & Oncology — Payments: $9,190
Hematology & Oncology $9,190
Ms. Addie Hill, M.d, M.D
Hematology & Oncology — Payments: $5,608
Hematology & Oncology $5,608
Dr. Pramod Gaudel, M.d, M.D
Hematology & Oncology — Payments: $5,452
Hematology & Oncology $5,452